Rustin Armknecht
Biography
Rustin Armknecht is an Executive Compensation & Benefits associate in Weil’s Tax Department and is based in New York. Rustin participates in the representation of Firm clients with respect to the executive compensation, employee benefits and ERISA issues in mergers, acquisitions, dispositions, initial public offerings and other strategic transactions.
Rustin has been part of the teams advising:
- Charlesbank Capital Partners and its portfolio company Bridges Consumer Healthcare in Bridges’ acquisition of KT Health, LLC
- DT Midstream, Inc. in its $1.2 billion acquisition of a portfolio of three FERC-regulated natural gas transmission pipelines from ONEOK, Inc.
- EP Wealth Advisors, LLC (a portfolio company of Berkshire Partners LLC) in its $500 million senior secured term loan and revolving facility
- Griffon Bidco, Inc. (a portfolio company of Advent International L.P.), in its senior secured term loan and revolving facility to finance the acquisition of LayerZero
- H.I.G. Capital in its $118 million acquisition of Quisitive Technology Solutions Inc. and its take-private acquisition of Converge Technology Solutions Corp.
- Hilco Global in sale of its majority stake to ORIX Corporation USA
- PX3 Partners and its portfolio company Cleanova in its acquisition of Micronics Engineered Filtration Group Inc.; in Cleanova's $705 million senior secured credit facilities to finance its acquisition of Micronics Filtration
- Stone Ridge Holdings Group in its acquisition of Wincoram Asset Management
- Stripes, LLC in its investment in Databricks, Inc.
Rustin received her J.D., cum laude, from Washington University School of Law, where she served as Staff Editor for the Washington University Law Review. She received her B.A., magna cum laude and Phi Beta Kappa, from Lafayette College.
Awards and Recognition, Speaking Engagements, Guides and Resources, Latest Thinking, Firm News & Announcements
Firm News & Announcements
- Weil Advises EP Wealth Advisors LLC in $500 Million Credit Facilities Deal Brief — October 21, 2025
- Weil Advises Goldman Sachs in Acquisition of Industry Ventures Deal Brief — October 13, 2025
- Weil Advises CPP Investments in its $1 Billion Investment in AlphaGen Deal Brief — October 03, 2025
- Weil Advises Remedy Meds on Acquisition of Thirty Madison Deal Brief — September 04, 2025
- Weil Advises the Private Equity Business at Goldman Sachs Alternatives in Acquisition of a Majority Stake in NAVEX Deal Brief — July 21, 2025